Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?

NCT05788276 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT05788276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
May 2, 2023
Completion date
June 30, 2028
Enrollment
330 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant failure, kidney transplant; complications, renal failure